Jonathan Herod

Jonathan Herod

Hamad Medical Corporation - Doha / Qatar
Medical and Health Sciences / Obstetrics and Gynecology
AD Scientific Index ID: 4698665
person_outline Jonathan Herod's MOST POPULAR ARTICLES
1-) Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial S Kehoe, J Hook, M Nankivell, GC Jayson, H Kitchener, T Lopes, ... The Lancet 386 (9990), 249-257, 2015 10842015
2-) Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialIJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ...The Lancet 387 (10022), 945-956, 20169972016
3-) Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK …U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ...The lancet oncology 10 (4), 327-340, 20099682009
4-) The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.AG Eliopoulos, DJ Kerr, J Herod, L Hodgkins, S Krajewski, JC Reed, ...Oncogene 11 (7), 1217-1228, 19954071995
5-) Radical vaginal trachelectomy as a fertility‐sparing procedure in women with early‐stage cervical cancer—cumulative pregnancy rate in a series of 123 womenJH Shepherd, C Spencer, J Herod, TEJ IndBJOG: An International Journal of Obstetrics & Gynaecology 113 (6), 719-724, 20063402006